ENTPD1 and tuberculosis: Future studies should prioritize delineating the spatiotemporal regulation of CD39 in TB granulomas, exploring its interactions with various immune cell subsets, and validating CD39-targeted therapies through preclinical models and, ultimately, randomized clinical trials to advance translational applications for TB diagnosis and treatment.